Ultromics collaborates with Mayo Clinic to optimize the impact of AI tools on care pathways – DOTmed HealthCare Business News

Ultromics, a health-tech company which applies AI to echocardiography, to earlier detect and better diagnose heart disease, has entered a know-how and clinical research agreement with Mayo Clinic. Underpinned by a determination to drive higher standards of patient care, the collaboration will leverage Mayos cardiology expertise and insights and feed real world data into Ultromics first product to market, EchoGo Core.

Mayo Clinic is one of the worlds leading centers of cardiology and its extensive cardiac datasets will assist Ultromics in the development of the companys image analysis product suite. The collaboration will be led by Ross Upton, CEO and founder of Ultromics and Patricia A. Pellikka, M.D. cardiologist and clinical researcher at Mayo Clinic, who this week joined Ultromics scientific advisory board. Mayo Clinic will also take an equity stake in the company.

EchoGo Core, cleared by the FDA for use by US physicians in November 2019, applies AI and automates the analysis of echocardiograms, measuring key cardiac parameters to support decision-making with zero variability.

1st FDA Approved Handheld Wireless Ultrasound Probe.Currently being used to fight COVID-19 in Wuhan China, South Korea, & within the USA.Features include Lung Ultrasound Scanning, & PACS Compatibility. ( CONTACT US TODAY TO RESERVE INVENTORY )

Announcing the agreement Ross Upton, said: Our absolute focus is on increasing the diagnostic accuracy of cardiovascular disease, which will ultimately help transform lives through the development of new diagnostic and predictive solutions.

About Ultromics Ultromics is a UK-based health technology firm, focused on bringing the benets of AI to support clinicians in the diagnosis of cardiovascular disease. Founded in 2017, Ultromics applies artificial intelligence to develop echo-based tools in cardiovascular imaging, by combining deep clinical insight with machine learning and some of the largest echo datasets in the world. The revolutionary platform assists clinicians in their decision-making, without disrupting clinical workow, to drive diagnostic quality and patient care. Cardiovascular disease is the number one global killer, causing an estimated 17 million deaths. Ultromics mission is to enable earlier detection of cardiovascular disease and improve patient outcomes. For more information about Ultromics visit https://ultromics.com/

About Mayo Clinic Mayo Clinic is a non-profit organization committed to clinical practice, education and research, providing expert, comprehensive care to everyone who needs healing. The Mayo Clinic Department of Cardiovascular Medicine is one of the largest and most comprehensive heart practices in the world. It includes more than 240 subspecialized experts trained in congenital heart disease in adults and children, coronary artery disease, hypertrophic cardiomyopathy, heart rhythm disorders, and heart valve diseases.

More:
Ultromics collaborates with Mayo Clinic to optimize the impact of AI tools on care pathways - DOTmed HealthCare Business News